control group:EGFR-TKI

2 trials

Sponsors

Shanghai Pulmonary Hospital, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

NSCLCnon-small cell lung cancer

Phase 4

A prospective, randomized, controlled study of the efficacy and safety of Fufang Banmao Capsule for treating advanced non-small cell lung cancer after EGFR-TKI therapy

Active, not recruitingChiCTR1900024240

Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNSCLC

Start: 2019-07-10Updated: 2019-07-15

Unknown Phase

The Study and Clinical Efficacy Evaluation of Yiqi Jiedu Tongluo Decoction combined with EGFR-TKI Delays Targeted Drug Resistance in Advanced Non-small Cell Lung Cancer

Active, not recruitingChiCTR1800018087

Shanghai Pulmonary Hospitalnon-small cell lung cancer

Start: 2019-05-01Updated: 2018-09-03